Taking Ozempic or Wegovy? 2 New Studies Link GLP-1 Drugs to 2 Unexpected Problems
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Taking Ozempic or Wegovy? 2 New Studies Link GLP-1 Drugs to 2 Unexpected Problems" is generating significant coverage in the Health category, with 2 articles from 2 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Gizmodo and MedPage Today. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 44d ago.
Quick answers
Why is "Taking Ozempic or Wegovy? 2 New Studies Link GLP-1 Drugs to 2 Unexpected Problem" trending?
Because 2 independent news sources published 2 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (4)
- New study suggests possible connection between GLP-1s and hair loss in men washingtonpost.com · 44d ago
- Study explores genetic link between GLP-1 drugs and male pattern hair loss ABC30 Fresno · 44d ago
- Hair Loss Was Just the Start. Ozempic Users Are Also Reporting Nail Trouble Gizmodo · 44d ago
- GLP-1s Tied to Detached Fingernails in New Study MedPage Today · 44d ago
Topics
Related trends
DJ Khaled reflects on using GLP-1s in 90-pound weight loss journey: ‘I needed help’
DJ Khaled publicly details a 75-to-90-pound weight loss aided by GLP-1 medication Wegovy, sparking wide entertainment-media coverage.
‘Star Wars: A New Hope’ Set For IMAX 70mm Re-Release
Lucasfilm plans to unveil its future Star Wars movie slate at Star Wars Celebration in London next April, ending a theatrical drought since 2019's The Rise of Skywalker.
Ozempic and Zepbound users face 6 rebound risks after stopping, doctor warns
Internal medicine physician Dr. Frank Dumont warns that stopping GLP-1 medications like Ozempic and Zepbound carries six rebound risks, including rapid weight regain, loss of cardiovascular protection, and worsening mental health.
‘Y&R’s New Head Writers Promise ‘Sexy’ Next Chapter and Cast Surprises
New head writers for 'The Young and the Restless' preview explosive shifts, a sexy next chapter, and major cast surprises.
FDA orders new warning labels on Ozempic, Wegovy over rare risk of permanent vision loss
Federal regulators mandate new vision loss warning labels across the widely used GLP-1 receptor agonist drug class.
FDA tells GLP-1 makers to warn of potential vision loss side effect
The FDA is requiring all GLP-1 drug makers to add warnings about a possible increased risk of NAION, a rare eye condition that can cause sudden and permanent vision loss.